Tokyo, Japan

Kunihiro Sasahara

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kunihiro Sasahara. Retrieved from https://idiyas.com/inventor/kunihiro-sasahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kunihiro Sasahara: Innovator in Anti-Diabetic Compounds

Introduction

Kunihiro Sasahara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anti-diabetic properties. His work has the potential to impact the treatment of diabetes in mammals.

Latest Patents

Sasahara holds a patent for "Thiazolidine derivatives with anti-diabetic activity, their preparation." This patent includes compounds of a specific formula that demonstrate anti-diabetic activity. The compounds are characterized by various groups and structures that enhance their effectiveness in treating diabetes.

Career Highlights

Kunihiro Sasahara is associated with Sankyo Company, Limited, where he has been involved in innovative research and development. His expertise in medicinal chemistry has led to advancements in the pharmaceutical industry, particularly in diabetes treatment.

Collaborations

Sasahara has worked alongside notable colleagues such as Takao Yoshioka and Takashi Fujita. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Kunihiro Sasahara's work in developing anti-diabetic compounds showcases his dedication to improving health outcomes. His contributions to the field are invaluable and highlight the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…